Related references
Note: Only part of the references are listed.Prominin-1 (CD133) Defines Both Stem and Non-Stem Cell Populations in CNS Development and Gliomas
Karl Holmberg Olausson et al.
PLOS ONE (2014)
Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma
Surasak Phuphanich et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Human Glioma-Initiating Cells Show a Distinct Immature Phenotype Resembling but Not Identical to NG2 Glia
Alonso Barrantes-Freer et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2013)
Expansion of CD 133-positive glioma cells in recurrent de novo glioblastomas after radiotherapy and chemotherapy Laboratory investigation
Kaoru Tamura et al.
JOURNAL OF NEUROSURGERY (2013)
CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges
Philipp Grosse-Gehling et al.
JOURNAL OF PATHOLOGY (2013)
Prominin 1/CD133 Endothelium Sustains Growth of Proneural Glioma
Bi-Sen Ding et al.
PLOS ONE (2013)
Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells
Yuanyan Wei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Impact of CD133 positive stem cell proportion on survival in patients with glioblastoma multiforme
Marju Kase et al.
RADIOLOGY AND ONCOLOGY (2013)
CD133 Is Essential for Glioblastoma Stem Cell Maintenance
Paola Brescia et al.
STEM CELLS (2013)
Characteristic Features of Stem Cells in Glioblastomas: From Cellular Biology to Genetics
Mark J. Knights et al.
BRAIN PATHOLOGY (2012)
Current Strategies for Identification of Glioma Stem Cells: Adequate or Unsatisfactory?
Paola Brescia et al.
JOURNAL OF ONCOLOGY (2012)
Thickness profiling of formaldehyde-fixed cells by transmission-through-dye microscopy
Mariana Pelts et al.
BIOTECHNIQUES (2011)
Haematopoietic stem cell differentiation promotes the release of prominin-1/CD133-containing membrane vesicles-a role of the endocytic-exocytic pathway
Nicola Bauer et al.
EMBO MOLECULAR MEDICINE (2011)
Insight into the complex regulation of CD133 in glioma
Benito Campos et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
CD133 Protein N-Glycosylation Processing Contributes to Cell Surface Recognition of the Primitive Cell Marker AC133 Epitope
Anthony B. Mak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The presence of stem cell marker-expressing cells is not prognostically significant in glioblastomas
Kyung-Jung Kim et al.
NEUROPATHOLOGY (2011)
A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations
Xiaowei Yan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
CD133 and membrane microdomains: Old facets for future hypotheses
Christine A. Fargeas et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions
J. D. Lathia et al.
CELL DEATH & DISEASE (2011)
A2B5 Cells from Human Glioblastoma have Cancer Stem Cell Properties
Aurelie Tchoghandjian et al.
BRAIN PATHOLOGY (2010)
A Hierarchy of Self-Renewing Tumor-Initiating Cell Types in Glioblastoma
Ruihuan Chen et al.
CANCER CELL (2010)
The AC133 Epitope, but not the CD133 Protein, Is Lost upon Cancer Stem Cell Differentiation
Kristel Kemper et al.
CANCER RESEARCH (2010)
Integrin Alpha 6 Regulates Glioblastoma Stem Cells
Justin D. Lathia et al.
CELL STEM CELL (2010)
The intriguing links between prominin-1 (CD133), cholesterol-based membrane microdomains, remodeling of apical plasma membrane protrusions, extracellular membrane particles, and (neuro)epithelial cell differentiation
Denis Corbeil et al.
FEBS LETTERS (2010)
Analysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarks
Kouichi Tabu et al.
MOLECULAR CANCER (2010)
How powerful is CD133 as a cancer stem cell marker in brain tumors?
Jin-Xiang Cheng et al.
CANCER TREATMENT REVIEWS (2009)
SSEA-1 Is an Enrichment Marker for Tumor-Initiating Cells in Human Glioblastoma
Myung Jin Son et al.
CELL STEM CELL (2009)
Limits of CD133 as a marker of glioma self-renewing cells
Virginie Clement et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays
Yifang Hu et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2009)
CD133 (Prominin) Negative Human Neural Stem Cells Are Clonogenic and Tripotent
Yirui Sun et al.
PLOS ONE (2009)
Cell cycle-dependent variation of a CD133 epitope in human embryonic stem cell, colon cancer, and melanoma cell lines
Marie Jaksch et al.
CANCER RESEARCH (2008)
Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors
Joo Mi Yi et al.
CANCER RESEARCH (2008)
Stem cell marker CD133 affects clinical outcome in glioma patients
Felix Zeppernick et al.
CLINICAL CANCER RESEARCH (2008)
CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells
Jian Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Stem cell-related Self-Renewal signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma
Anastasia Murat et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells
Scott Bidlingmaier et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas
Kyeung Min Joo et al.
LABORATORY INVESTIGATION (2008)
CD133 Is a Marker of Bioenergetic Stress in Human Glioma
Corinne E. Griguer et al.
PLOS ONE (2008)
Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria
H. S. Guenther et al.
ONCOGENE (2008)
CD133+ and CD133- glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles
Dagmar Beier et al.
CANCER RESEARCH (2007)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Analysis of gene expression and chemoresistance of CDI33+ cancer stem cells in glioblastoma
Gentao Liu et al.
MOLECULAR CANCER (2006)
Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer
M Florek et al.
CELL AND TISSUE RESEARCH (2005)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
AC133 antigen, CD133, prominin-1, prominin-2, etc.: Prominin family gene products in need of a rational nomenclature
CA Fargeas et al.
STEM CELLS (2003)
The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions
D Corbeil et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
